Recurrence after Mastectomy for Ductal Carcinoma In Situ

By Godat Laura N.   Horton Janet K.   Shen Perry   Stewart John H.   Wentworth Stacy   Levine Edward A.  

The American Surgeon, Vol. 75, Iss. 7, 2009-07 ,pp. : 592-597

Southeastern Surgical Congress

Access to resources Recommend Favorite

Does Time to Definitive Treatment Matter in Patients with Ductal Carcinoma in Situ?

By Sue Gloria R.   Lannin Donald R.   Killelea Brigid   Tsangaris Theodore   Chagpar. Anees B.  

The American Surgeon, Vol. 79, Iss. 6, 2013-06 ,pp. : 561-565

Southeastern Surgical Congress

Access to resources Recommend Favorite

Presence of carcinoma in situ and high 2c-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt

By van Rhijn B.W.G.   van der Poel H.G.   Boon M.E.   Debruyne F.M.J.   Schalken J.A.   Witjes J.A.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 363-367

Elsevier

Access to resources Recommend Favorite

The Use of Sentinel Lymph Node Biopsy in Ductal Carcinoma In Situ

By Schneider Christopher   Trocha Steven   McKinley Brian   Shaw Jamie   Bielby S.   Blackhurst Dawn   Jones Yonge   Cornett Wendy  

The American Surgeon, Vol. 76, Iss. 9, 2010-09 ,pp. : 943-946

Southeastern Surgical Congress

Access to resources Recommend Favorite

Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ

By Kotwall C.   Brinker C.   Covington D.   Hall T.   Hamann M.S.   Maxwell J.G.   Stiles A.   Weiss A.  

The American Journal of Surgery, Vol. 186, Iss. 6, 2003-12 ,pp. : 723-729

Elsevier

Access to resources Recommend Favorite